WO2008139229A3 - Pores - Google Patents
Pores Download PDFInfo
- Publication number
- WO2008139229A3 WO2008139229A3 PCT/GB2008/050351 GB2008050351W WO2008139229A3 WO 2008139229 A3 WO2008139229 A3 WO 2008139229A3 GB 2008050351 W GB2008050351 W GB 2008050351W WO 2008139229 A3 WO2008139229 A3 WO 2008139229A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pore
- pores
- dendimer
- lumen
- polypeptides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/595—Polyamides, e.g. nylon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
Abstract
The present invention relates a nanoscale pore having a lumen, wherein a dendimer is attached to the pore, and also to a membrane comprising the pore. The invention has applications in filtration devices, sequencing nucleic acids or polypeptides, and the coatings of pharmaceutical compositions.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0709259.6A GB0709259D0 (en) | 2007-05-14 | 2007-05-14 | Pores |
GB0709259.6 | 2007-05-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008139229A2 WO2008139229A2 (en) | 2008-11-20 |
WO2008139229A3 true WO2008139229A3 (en) | 2009-03-19 |
Family
ID=38219386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2008/050351 WO2008139229A2 (en) | 2007-05-14 | 2008-05-14 | Pores |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0709259D0 (en) |
WO (1) | WO2008139229A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106589401A (en) * | 2017-01-04 | 2017-04-26 | 安庆师范大学 | Preparation method of P-containing silica gel-supported PAMAM type dendritic polymer |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105778895B (en) * | 2016-04-08 | 2018-08-28 | 兰州文理学院 | The preparation of CdS/PAMAM nanocomposites and detection Cu2+In application |
CN111701467B (en) * | 2020-05-26 | 2022-05-10 | 浙江工业大学 | Method for improving pollution resistance of homogeneous pore membrane by utilizing covalent bond layer-by-layer self-assembly |
CN113735098B (en) * | 2020-05-29 | 2023-08-22 | 中国石油天然气股份有限公司 | Nitrogen-doped carbon nano ring, and preparation method and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6472571B1 (en) * | 1999-10-01 | 2002-10-29 | Degussa-Huls Ag | Process for the production of organic compounds in a membrane reactor |
US20040063200A1 (en) * | 2000-07-28 | 2004-04-01 | Elliot Chaikof | Biological component comprising artificial membrane |
WO2005009602A2 (en) * | 2003-07-22 | 2005-02-03 | Iowa State University Research Foundation, Inc. | Capped mesoporous silicates |
-
2007
- 2007-05-14 GB GBGB0709259.6A patent/GB0709259D0/en not_active Ceased
-
2008
- 2008-05-14 WO PCT/GB2008/050351 patent/WO2008139229A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6472571B1 (en) * | 1999-10-01 | 2002-10-29 | Degussa-Huls Ag | Process for the production of organic compounds in a membrane reactor |
US20040063200A1 (en) * | 2000-07-28 | 2004-04-01 | Elliot Chaikof | Biological component comprising artificial membrane |
WO2005009602A2 (en) * | 2003-07-22 | 2005-02-03 | Iowa State University Research Foundation, Inc. | Capped mesoporous silicates |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106589401A (en) * | 2017-01-04 | 2017-04-26 | 安庆师范大学 | Preparation method of P-containing silica gel-supported PAMAM type dendritic polymer |
CN106589401B (en) * | 2017-01-04 | 2020-07-14 | 安庆师范大学 | Preparation method of P-containing silica gel loaded PAMAM type dendritic macromolecule |
Also Published As
Publication number | Publication date |
---|---|
GB0709259D0 (en) | 2007-06-20 |
WO2008139229A2 (en) | 2008-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008103599A3 (en) | Composition, its use in the preparation of membranes, and systems comprising the membranes | |
GB0819330D0 (en) | Nanopore electrode, nanopore membrane, methods of preparation and surface modification, and use thereof | |
IL199850A0 (en) | Modified porous membranes, methods of membrane pore modification, and methods of use thereof | |
EP1874443A4 (en) | Ultrathin porous nanoscale membranes, methods of making, and uses thereof | |
WO2003063995A3 (en) | Spiraled surface hollow fiber membranes | |
IL197625A0 (en) | Polymer-based filtration membranes and methods of producing the same | |
WO2007136504A3 (en) | Medical devices having bioactive surfaces | |
EP3409765A3 (en) | Ketoreductase-mediated stereoselective route to alpha chloroalcohols | |
WO2008089109A3 (en) | Biomimetic hydroxyapatite composite materials and methods for the preparation thereof | |
WO2008140496A3 (en) | Preparation and purification of ionic liquids and precursors | |
GB2448014B (en) | Coated asymmetric membrane system having olepohobic and hydrophilic properties | |
EP2335814A4 (en) | Use of porous hollow-fiber membrane for producing clarified biomedical culture medium | |
NL1030346A1 (en) | Semi-permeable composite membrane, production method thereof, and element, fluid separation plant and method for treatment of water using the same. | |
EP1888238A4 (en) | Uses of parylene membrane filters | |
GB0704797D0 (en) | Membrane structures and their production and use | |
WO2008115694A3 (en) | Polymerization of multifunctional azides, and polymers therefrom | |
NL1030288A1 (en) | Semi-permeable composite membrane, production method thereof, and element, fluid separation plant and method for treatment of water using the same. | |
WO2009027186A3 (en) | Hyperbranched polymers comprising guanidine units | |
WO2007140910A3 (en) | Porous membrane comprising a biocompatible block-copolymer | |
WO2007103775A3 (en) | Biomaterials having nanoscale layers and coatings | |
CA2695061C (en) | Sdf-1 binding nucleic acids and the use thereof | |
EP2266932B8 (en) | Porous ceramic member and filter | |
EP1993717A4 (en) | Tio2 nanostructures, membranes and films, and methods of making same | |
IL185848A0 (en) | Manufacture of membranes for desalination and filtration | |
WO2008139229A3 (en) | Pores |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08750750 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08750750 Country of ref document: EP Kind code of ref document: A2 |